Zurich Cantonal Bank’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252K Hold
3,675
﹤0.01% 2249
2026
Q1
$236K Buy
+3,675
New +$335K ﹤0.01% 2193
2025
Q4
Sell
-3,702
Closed -$508K 3428
2025
Q3
$399K Buy
3,702
+181
+5% +$19.7K ﹤0.01% 1862
2025
Q2
$325K Buy
3,521
+1,297
+58% +$102K ﹤0.01% 1910
2025
Q1
$197K Buy
2,224
+1,443
+185% +$125K ﹤0.01% 2111
2024
Q4
$60K Buy
+781
New +$54.6K ﹤0.01% 2541
2023
Q1
Sell
-685
Closed -$5.96K 2878
2022
Q4
$5.96K Hold
685
﹤0.01% 2823
2022
Q3
$20K Hold
685
﹤0.01% 2805
2022
Q2
$28K Buy
+685
New +$46.5K ﹤0.01% 2743
2022
Q1
Sell
-685
Closed -$101K 2851
2021
Q4
$101K Buy
+685
New +$153K ﹤0.01% 2508

Other funds holding WGS

Zurich Cantonal Bank's WGS Position: Q2 2026 in Review

Zurich Cantonal Bank held its GeneDx Holdings (WGS) position steady in Q2 2026 at 3,675 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

Zurich Cantonal Bank first reported a position in WGS in Q4 2021 and has held it in 10 quarters since. The position peaked at $399K in Q3 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Zurich Cantonal Bank held 3,675 shares of GeneDx Holdings worth $252K as of Q2 2026.
  • Zurich Cantonal Bank left its GeneDx Holdings share count unchanged in Q2 2026.
  • GeneDx Holdings made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2249 holding.
  • Zurich Cantonal Bank first reported a position in GeneDx Holdings in Q4 2021 and has held it in 10 quarters since.
  • Zurich Cantonal Bank's GeneDx Holdings position peaked at $399K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.